InvestorsHub Logo
Followers 789
Posts 118193
Boards Moderated 19
Alias Born 09/05/2002

Re: None

Thursday, 09/15/2022 10:20:01 AM

Thursday, September 15, 2022 10:20:01 AM

Post# of 1161
Opdivo monotherapy shows statsig RFS in adjuvant melanoma (fully resected Stage IIB/C):

https://finance.yahoo.com/news/bristol-myers-squibb-announces-adjuvant-105900730.html

These results are from the phase-3 CHECKMATE-76K trial. Details to be presented at a medical conference.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News